Anti‐apoptotic protein BCL‐XL as a therapeutic vulnerability in gastric cancer

BACKGROUND: New therapeutic targets are needed to improve the outcomes for gastric cancer (GC) patients with advanced disease. Evasion of programmed cell death (apoptosis) is a hallmark of cancer cells and direct induction of apoptosis by targeting the pro‐survival BCL2 family proteins represents a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yumin, Zhang, Liping, Wang, Chao, Li, Zefeng, Luo, Mingjie, Xie, Guomin, Yang, Xingjiu, Li, Mengyuan, Ren, Shuyue, Zhao, Dongbing, Gao, Ran, Gong, Jia‐Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272913/
https://www.ncbi.nlm.nih.gov/pubmed/37271936
http://dx.doi.org/10.1002/ame2.12330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272913/
https://www.ncbi.nlm.nih.gov/pubmed/37271936
http://dx.doi.org/10.1002/ame2.12330

Ejemplares similares